Short sellers are pressing their bets hard. Wolfspeed tops the conviction list with short interest at 103% of free float — a near-impossible squeeze setup with zero borrow availability. AI chip hopeful Cerebras Systems has drawn fresh fire too. Its SI hit 32.4% of free float, up 7 points in a week. Bears appear unconvinced by its $8bn valuation. Meanwhile, Birkenstock is bucking the trend. Short covering accelerated, cutting SI by 3.5 points to 26.8%. Closing those shorts still costs 21.4% annually to borrow.
The insider tape tells two very different stories. Summit Therapeutics CEO Robert Duggan filed a $50M purchase of SMMT shares this month. That is 0.74% of the company in one trade. Applied Materials executives moved the opposite way. CEO Gary Dickerson and others filed over $100M in combined sales in two days. also saw heavy C-suite selling, with $38M in filings across two executives.
lululemon and Accenture both had consensus price targets trimmed this week. Accenture's target dropped over $10, and not one analyst has a buy rating. Take-Two Interactive stood out on the positive side. Its target rose to $279.45 and 28 analysts rate it a buy.
Markets face a heavy earnings schedule. Micron reports Wednesday — the key chip bellwether for AI memory demand. FedEx reports Tuesday, giving investors freight and margin signals. Carnival also posts Tuesday. Options traders are already stacking near-term expiries on all three names ahead of the releases.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
